Medical illustration showing Enterococcus faecalis bacteria producing hydrogen peroxide to stall chronic wound healing, with catalase enzyme restoring skin cell migration.
Medical illustration showing Enterococcus faecalis bacteria producing hydrogen peroxide to stall chronic wound healing, with catalase enzyme restoring skin cell migration.
Изображение, созданное ИИ

Study links Enterococcus faecalis metabolism to stalled healing in chronic wounds

Изображение, созданное ИИ
Проверено фактами

Researchers report that Enterococcus faecalis—a bacterium often found in chronic wounds—can hinder skin repair by generating hydrogen peroxide through a metabolic pathway, triggering stress responses that stop key skin cells from migrating. In laboratory experiments, breaking down the peroxide with the antioxidant enzyme catalase helped restore cell movement, suggesting a potential treatment approach that does not rely on antibiotics.

Chronic wounds are a growing health challenge and can lead to serious complications, including amputation. An international research team says it has identified a mechanism by which a common wound-associated bacterium, Enterococcus faecalis, can directly interfere with the body’s ability to repair damaged skin.

In a study published in Science Advances, the researchers—led by Associate Professor Guillaume Thibault of Nanyang Technological University (NTU) in Singapore and Professor Kimberly Kline of the University of Geneva—found that E. faecalis can impair wound closure not only by surviving treatment, but by producing reactive oxygen species as a byproduct of its metabolism.

The team reports that E. faecalis uses a metabolic process known as extracellular electron transport (EET) that generates hydrogen peroxide. In lab experiments with human skin cells, hydrogen peroxide induced oxidative stress in keratinocytes, cells that help close wounds. That stress activated the unfolded protein response, a cellular pathway that can be protective but, in this setting, was linked to reduced keratinocyte migration—slowing the process needed to seal damaged tissue.

To test the role of EET, the researchers used a genetically modified E. faecalis strain lacking the EET pathway. Those bacteria produced substantially less hydrogen peroxide and were less able to block keratinocyte migration in laboratory assays, the study found.

The team also tested whether neutralizing hydrogen peroxide could reverse the effect. Treating skin cells with catalase—an antioxidant enzyme that breaks down hydrogen peroxide—reduced stress signaling and helped restore keratinocyte migration in lab experiments.

“Our findings show that the bacteria’s metabolism itself is the weapon, which was a surprise finding previously unknown to scientists,” Thibault said in NTU’s statement about the work.

The researchers said the results point to a treatment strategy that could complement or, in some cases, reduce reliance on antibiotics: targeting harmful bacterial byproducts rather than attempting to eliminate bacteria outright. They suggested that wound dressings infused with antioxidants such as catalase could be a practical avenue for further development.

The group said it is conducting studies in animal models to determine effective delivery methods before moving toward human clinical trials.

Что говорят люди

Initial reactions on X to the study linking Enterococcus faecalis metabolism to stalled healing in chronic wounds via hydrogen peroxide production are limited to shares from science and biotech accounts. Posters highlight the potential of antioxidant enzymes like catalase in wound dressings as a non-antibiotic treatment approach.

Связанные статьи

Lab illustration of Paracoccus sanguinis bacteria from blood producing anti-aging indole metabolites that rejuvenate human skin cells, reducing stress and inflammation.
Изображение, созданное ИИ

Blood-dwelling bacterium yields indole metabolites with anti-aging effects in skin cells

Сообщено ИИ Изображение, созданное ИИ Проверено фактами

Researchers have identified indole metabolites from the human blood bacterium Paracoccus sanguinis that showed anti-aging activity in laboratory-grown human skin cells. The compounds reduced oxidative stress, inflammation and collagen-degrading activity in cell experiments, according to findings published in the Journal of Natural Products.

Researchers at the University of Waterloo have developed engineered bacteria designed to invade and eat solid tumors from the inside out. The approach uses microbes that thrive in oxygen-free environments, targeting the low-oxygen cores of tumors. A genetic modification allows the bacteria to survive near oxygenated edges, controlled by a quorum-sensing mechanism.

Сообщено ИИ Проверено фактами

Researchers report that small doses of the antibiotic cephaloridine can prompt certain gut bacteria to increase production of colanic acid, a microbial polysaccharide previously tied to longer lifespan in laboratory animals. In experiments, treated roundworms lived longer and mice showed shifts in cholesterol or insulin measures associated with aging, with the team arguing the approach works by acting in the gut rather than throughout the body.

After 11 years of research, scientists at McMaster University have identified a molecule called butyrolactol A that weakens deadly fungi, making them vulnerable to existing treatments. This discovery targets pathogens like Cryptococcus neoformans, which pose severe risks to immunocompromised individuals. The finding could revive outdated antifungal drugs amid rising resistance.

Сообщено ИИ Проверено фактами

Researchers at Arizona State University report that SerpinB3 — a protein better known as a cancer biomarker — plays a natural role in wound repair by spurring skin cells to migrate and rebuild tissue. The peer‑reviewed study appears in Proceedings of the National Academy of Sciences.

Researchers working at Harvard University and collaborators in Brazil have identified metabolites produced by gut bacteria that travel through the portal vein to the liver and appear to influence energy use and insulin sensitivity in mice. The findings, published in Cell Metabolism, suggest possible new strategies for preventing or treating obesity and type 2 diabetes by targeting gut–liver communication.([sciencedaily.com](https://www.sciencedaily.com/releases/2025/12/251214100926.htm?utm_source=openai))

Сообщено ИИ Проверено фактами

Australian researchers report they have engineered monoclonal antibodies that recognize pseudaminic acid—a sugar made by bacteria but not by humans—and used them to help eliminate multidrug-resistant Acinetobacter baumannii infections in mice, a step toward potential passive-immunotherapy treatments for hard-to-treat hospital infections.

 

 

 

Этот сайт использует куки

Мы используем куки для анализа, чтобы улучшить наш сайт. Прочитайте нашу политику конфиденциальности для дополнительной информации.
Отклонить